References
- Children: reducing mortality. Fact Sheet N°178. World Health Organization, 2014. Available at: http://www.who.int/mediacentre/factsheets/fs178/en/ [Last accessed 14 August 2015]
- Gaffey MF, Das JK, Bhutta ZA. Millennium Development Goals 4 and 5: past and future progress. Semin Fetal Neonatal Med 2015: published online Aug 12, doi: 10.1016/j.siny.2015.07.001
- Brugha R, Starling M, Walt G. GAVI, the first steps: lessons for the Global Fund. Lancet 2002;359:435-8
- Hinman AR, McKinlay MA. Immunization equity. Am J Prev Med 2015: published online Aug 14, doi: 10.1016/j.amepre.2015.04.018
- Press release: political support crucial to reach ‘the fifth child' with vaccines. UNICEF, 2013. Available at: http://www.unicef.org/media/media_68809.html [Last accessed 14 August 2015]
- Global immunization data. World Health Organization, UNICEF, 2014. Available at: http://www.who.int/immunization/monitoring_surveillance/global_immunization_data.pdf [Last accessed 14 August 2015]
- Bairwa M, Pilania M, Rajput M, et al. Pentavalent vaccine. A major breakthrough in India's Universal Immunization Program. Hum Vaccin Immunother 2012;8:1314-16
- VVM history and milestones. World Health Organization, 2015. Available at: http://www.who.int/immunization_standards/vaccine_quality/VVM_history_milestones.pdf?ua=1 [Last accessed 14 August 2015]
- Cold-chain: the last child, the last mile. UNICEF, 2014. Available at: http://www.unicef.org/supply/index_68352.html [Last accessed 14 August 2015]
- Finding the final fifth. Inequalities in immunisation. Save the Children, 2012. Available at: http://www.savethechildren.org.uk/sites/default/files/docs/Finding-the-Final-Fifth.pdf [Last accessed 14 August 2015]
- Stokes-Prindle C, Privor-Dumm L, Haidari L, et al. Coverage, cost, and safety impacts of primary container choice. International Vaccine Access Center. 2013. Available at: http://www.jhsph.edu/research/centers-and-institutes/ivac/projects/IVAC-PrimaryContainerBriefReport-2013.pdf [Last accessed 14 August 2015]
- Kassahun MB, Biks GA, Teferra AS. Level of immunization coverage and associated factors among children aged 12–23 months in Lay Armachiho District, North Gondar Zone, Northwest Ethiopia: a community based cross sectional study. BMC Res Notes 2015;8:239
- Hu Y, Li Q, Chen E, et al. Determinants of childhood immunization uptake among socio-economically disadvantaged migrants in East China. Int J Environ Res Public Health 2013;10:2845-56
- Kusuma YS, Kumari R, Pandav CS, Gupta SK. Migration and immunization: determinants of childhood immunization uptake among socioeconomically disadvantaged migrants in Delhi, India. Trop Med Int Health 2010;15:1326-32
- Holt E. Ukraine at risk of polio outbreak. Lancet 2013;381:2244
- Senessie C, Gage GN, von Elm E. Delays in childhood immunization in a conflict area: a study from Sierra Leone during civil war. Confl Health 2007;1:14
- Pépin J, Abou Chakra CN, Pépin E, et al. Evolution of the global burden of viral infections from unsafe medical injections, 2000–2010. PLoS One 2014;9:e99677
- WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings. World Health Organization, 2015. Available at: http://www.who.int/injection_safety/global-campaign/injection-safety_guidline.pdf [Last accessed 14 August 2015]
- Final evaluation of Gavi Alliance’s support to Bosnia and Herzegovina. Final Evaluation Report. July 31, 2014. Gavi, The Vaccine Alliance, 2014. Available at: http://www.gavi.org/Results/Evaluations/Gavi-support-to-Bosnia-and-Herzegovina-evaluation/ [Last accessed 14 August 2015]
- SAGE October 2014. Strategic Advisory Group of Experts on Immunization 21–23 October 2014. World Health Organization Department of Immunization, Vaccines and Biologicals (IVB), 2014. Available at: http://www.who.int/immunization/sage/meetings/2014/october/Yellow-bookSAGE2014_final.pdf [Last accessed 14 August 2015]
- Gavi Board meeting, 18–19 June 2014. Gavi, The Vaccine Alliance, 2014. Available at: http://www.gavi.org/about/governance/gavi-board/minutes/2014/18-june/ [Last accessed 14 August 2015]
- Alcock R, Cottingham MG, Rollier CS, et al. Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass. Sci Transl Med 2010;2:19ra12
- Pearson FE, McNeilly CL, Crichton ML, et al. Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice. PLoS One 2013;8:e67888
- The radically simple Uniject™ injection system. PATH, 2014. Available at: http://path.org/projects/uniject.php [Last accessed 14 August 2015]
- Global Immunization News. 29 February 2012. World Health Organization, 2012. Available at: http://www.who.int/immunization/GIN_February_2012.pdf [Last accessed 14 August 2015]
- Colombini A, Guillermet E, Dicko HM, et al. Optimal approaches for the use of DTP-HepB-Hib vaccine in a compact prefilled auto disable (cPAD) syringe in resource-poor settings. 16th International Congress on Infectious Diseases, Cape Town, South Africa, 2–5 April 2014
- Pentavalent vaccine in the Uniject™ injection system. A time and motion study. PATH, 2014. Available at: http://www.path.org/publications/files/TS_pentavalent_vac.pdf [Last accessed 14 August 2015]
- Kasi SG, Prabhu SV, Sanjay S, et al. Prefilled syringes versus vials: impact on vaccination efficiency and patient safety in Indian private market. Pediatr Infect Dis 2013;5:181-6
- The Uniject injection system: multi-country experience and evidence. Briefing Summary. PATH, 2011. Available at: http://www.path.org/publications/files/RH_depo_subq_experience.pdf [Last accessed 14 August 2015]
- Kristensen D. Case study: the Uniject™ injection system. Global Vaccine and Immunization Research Forum. 2014. Available at: http://www.who.int/immunization/research/forums_and_initiatives/03_Kristensen_GVIRF14_Uniject.pdf [Last accessed 14 August 2015]
- Immunization standards. WHO prequalified vaccines. World Health Organization, 2014. Available at: http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/ [Last accessed 14 August 2015]
- Sutanto A, Suarnawa IM, Nelson CM, et al. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull World Health Organ 1999;77:119-26
- Stakeholder perceptions of pentavalent vaccine (DTwP-HepB-Hib) in the Uniject™ injection system. PATH, Peruvian Ministry of Health, World Health Organization, 2014. Available at: http://www.path.org/publications/files/TS_dtwp_hepb_hib.pdf [Last accessed 14 August 2015]
- Nogier C, Hanlon P, Wiedenmayer K, Maire N. Can a compact pre-filled auto-disable injection system (cPAD) save costs for DTP-HepB-Hib vaccine as compared with single-dose (SDV) and multi-dose vials (MDV)? Evidence from Cambodia, Ghana, and Peru. Drugs Real World Outcomes 2015;2:43-52
- Humphreys G. Vaccination: rattling the supply chain. Bull World Health Organ 2011;89:324-5
- Zaffran M, Vandelaer J, Kristensen D, et al. The imperative for stronger vaccine supply and logistics systems. Vaccine 2013;31(Suppl 2):B73-80
- McCarney S, Zaffran M. Controlled Temperature Chain – the new term for Out of the Cold Chain. 2009. Available at: http://www.technet-21.org/en/resources/documents/cold-chain-equipment/725-controlled-temperature-chain-the-new-term-for-out-of-the-cold-chain/file [Last accessed 14 August 2015]
- Ren Q, Xiong H, Li Y, et al. Evaluation of an outside-the-cold-chain vaccine delivery strategy in remote regions of western China. Public Health Rep 2009;124:745-50
- Halm A, Yalcouyé I, Kamissoko M, et al. Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in Mali. Vaccine 2010;28:3467-72
- Hipgrave DB, Tran TN, Huong VM, et al. Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam. Am J Trop Med Hyg 2006;74:255-60
- Use of the MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns. Guidance for immunization programme decision-makers and managers. World Health Organization, 2014. Available at: http://apps.who.int/iris/bitstream/10665/86018/1/WHO_IVB_13.04_eng.pdf [Last accessed 14 August 2015]
- Meningococcal A conjugate 10 dose presentation. World Health Organization, 2013. Available at: http://www.who.int/immunization_standards/vaccine_quality/PQ_197_MenAconjugate_10dose_SII/en/ [Last accessed 14 August 2015]
- Juan-Giner A, Domicent C, Langendorf C, et al. A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain. Vaccine 2014;32:6220-6
- The controlled temperature chain (CTC): frequently asked questions. World Health Organization Department of Immunization, Vaccines and Biologicals, 2015. Available at: http://www.who.int/immunization/programmes_systems/supply_chain/resources/Controlled-Temperature-Chain-FAQ.pdf [Last accessed 14 August 2015]